NeonMind Biosciences Financials

NeonMind Biosciences Stock Summary

NeonMind Biosciences competes with ATAI Life, Mind Medicine, GH Research, Cybin, and X4 Pharmaceuticals. NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp. Neonmind Biosciences is traded on OTC Exchange in the United States.

NeonMind Biosciences Key Financial Ratios

There are many critical financial ratios that NeonMind Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NeonMind Biosciences reports annually and quarterly.

NeonMind Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NeonMind Biosciences's current stock value. Our valuation model uses many indicators to compare NeonMind Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeonMind Biosciences competition to find correlations between indicators driving NeonMind Biosciences's intrinsic value. More Info.NeonMind Biosciences is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeonMind Biosciences' earnings, one of the primary drivers of an investment's value.

NeonMind Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of NeonMind Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NeonMind Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeonMind Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing NeonMind Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeonMind Biosciences's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.